| Industry | 批发和零售业 | ||||||||||||||||||||||||
| Company Introduction | 南京医药股份有限公司是国内首家医药流通类上市公司,主要的产品包括各类中药、西药等.在南京市场上经营多年,拥有良好的终端和渠道优势.目前公司在南京药品市场上拥有40%以上的份额,实力远高于其它南京地区的商业公司,而且公司在苏北(盐城、南通、仪征)合肥、福州拥有很高的市场份额,在当地具有很强的竞争优势.2005年公司的商业销售额达到62亿,在国内仅次于国药、上药、九州通,具有规模优势。 | ||||||||||||||||||||||||
| Main Business | 经营药品、医疗器械、化学试剂、玻璃仪器四大类商品以及医药产品的研制、开发、生产、销售 | ||||||||||||||||||||||||
| Legal Representative | 周建军 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | -- | ||||||||||||||||||||||||
| Solicitors | 北京市竞天公诚律师事务所 | ||||||||||||||||||||||||
| Auditors | 毕马威华振会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
| Tel No | 025-84552601;025-84552680 | ||||||||||||||||||||||||
| Fax No | 025-84552680;025-84552601 | ||||||||||||||||||||||||
| Website | www.njyy.com | ||||||||||||||||||||||||
| 600713@njyy.com；liwenjun1@njyy.com；wangguan@njyy.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 01/07/1996 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.445 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.160 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 4.912 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 5.569B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |